1.90
price up icon4.97%   0.09
after-market アフターアワーズ: 1.89 -0.01 -0.53%
loading

Mindwalk Holdings Corp (HYFT) 最新ニュース

pulisher
02:38 AM

MindWalk Holdings Reports Q3 2025 Financial Results and Strategic Growth - MSN

02:38 AM
pulisher
Oct 09, 2025

MindWalk (HYFT) Announces Share Repurchase Plan - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk Holdings (HYFT) Announces 2.3M Share Buyback Program - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk Holdings Corp. authorizes a Buyback Plan. - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk Holdings Corp. announces an Equity Buyback for 2,300,000 shares. - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk Holdings announces 2.3M share buyback program - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk announces $2.3 million share repurchase program By Investing.com - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk Holdings Initiates Share Repurchase Program to Enhance Shareholder Value - TipRanks

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk announces $2.3 million share repurchase program - Investing.com India

Oct 09, 2025
pulisher
Oct 09, 2025

MindWalk Announces Share Repurchase Program - The Joplin Globe

Oct 09, 2025
pulisher
Sep 25, 2025

MindWalk Unveils Dual-Pathway Regimen in Longevity Therapeutics - MSN

Sep 25, 2025
pulisher
Sep 23, 2025

MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand - Insider Monkey

Sep 23, 2025
pulisher
Sep 23, 2025

MindWalk expands GLP-1 program with AI-discovered longevity pathway By Investing.com - Investing.com Nigeria

Sep 23, 2025
pulisher
Sep 22, 2025

MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - The AI Journal

Sep 22, 2025
pulisher
Sep 22, 2025

Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform (09/22/2025 00:00 - MarketScreener

Sep 22, 2025
pulisher
Sep 22, 2025

MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement By Investing.com - Investing.com South Africa

Sep 22, 2025
pulisher
Sep 22, 2025

MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement - Investing.com

Sep 22, 2025
pulisher
Sep 22, 2025

MindWalk (HYFT) Unveils Breakthrough in GLP-1 Therapeutic Progra - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

MindWalk expands GLP-1 program with AI-discovered longevity pathway - Investing.com

Sep 22, 2025
pulisher
Sep 22, 2025

MindWalk advances AI-designed GLP-1 program with first-in-class dual-pathway regimen for aging and longevity - MarketScreener

Sep 22, 2025
pulisher
Sep 17, 2025

MindWalk : Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform - MarketScreener

Sep 17, 2025
pulisher
Sep 16, 2025

How MindWalk Holdings' Rebranding and Improved Earnings May Impact HYFT Investors - Yahoo Finance

Sep 16, 2025
pulisher
Sep 16, 2025

MindWalk Holdings Reports Strong Revenue Growth and Improved Margins - TipRanks

Sep 16, 2025
pulisher
Sep 16, 2025

MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance

Sep 16, 2025
pulisher
Sep 16, 2025

MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Rebranding - GuruFocus

Sep 16, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Corp reports results for the quarter ended July 31Earnings Summary - TradingView

Sep 15, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Corp. Reports Earnings Results for the First Quarter Ended July 31, 2025 - MarketScreener

Sep 15, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly - PharmiWeb.com

Sep 15, 2025
pulisher
Sep 15, 2025

Earnings call transcript: MindWalk Inc. reports strong Q1 2025 performance, rebrands from ImmunoPrecise Antibodies - Investing.com UK

Sep 15, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Sep 15, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet - Business Wire

Sep 15, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Reports Record Revenue and Strategic Divestiture - TipRanks

Sep 15, 2025
pulisher
Sep 15, 2025

MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet | FinancialContent - FinancialContent

Sep 15, 2025
pulisher
Sep 12, 2025

MindWalk : 2025 Combined Financial Statements - MarketScreener

Sep 12, 2025
pulisher
Sep 10, 2025

MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025 - Business Wire

Sep 10, 2025
pulisher
Sep 05, 2025

MindWalk Holdings Corp.HYFTStock Price Today - Zacks Investment Research

Sep 05, 2025
pulisher
Sep 04, 2025

HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView

Sep 04, 2025
pulisher
Sep 04, 2025

ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT By Investing.com - Investing.com Canada

Sep 04, 2025
pulisher
Sep 03, 2025

HYFT's Rebranding: A Strategic Pivot in Biotech's AI-Driven Future - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Immunoprecise rebrands as Mindwalk, announces Nasdaq ticker change to "HYFT" - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - FinancialContent

Sep 03, 2025
pulisher
Sep 03, 2025

ImmunoPrecise Rebrands as MindWalk, Changes Nasdaq Ticker to HYFT - MarketScreener

Sep 03, 2025
pulisher
Sep 02, 2025

Leading Biotech ImmunoPrecise Antibodies Joins Major H.C. Wainwright Investment Conference in New York - Stock Titan

Sep 02, 2025
pulisher
Aug 27, 2025

AI-Powered Universal Dengue Vaccine Breakthrough: ImmunoPrecise's LENSai Platform Advances to Animal Studies - Stock Titan

Aug 27, 2025
pulisher
Aug 06, 2025

Strategic Acquisition: AVS Bio Expands Global Biologics Reach with ImmunoPrecise Europe Buyout - Stock Titan

Aug 06, 2025
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
大文字化:     |  ボリューム (24 時間):